Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05086224 · ClinicalTrials.gov registry record · Early Phase 1

Hematoma Block Versus Bier Block for Closed Fracture Reduction

A Early Phase 1 study of Distal Radius Fractures, sponsored by University of Utah.

Active
Registry status
Early Phase 1
Development phase
500
Enrollment target
1
Study location

NCT05086224: Active Early Phase 1 study of Distal Radius Fractures, sponsored by University of Utah.

NCT05086224 is a Early Phase 1 study of Distal Radius Fractures that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 500 participants, above the 71-participant average among 4 other Distal Radius Fractures trials with a reported enrollment target (604% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05086224, a Early Phase 1 study of Distal Radius Fractures, is active but no longer recruiting, sponsored by University of Utah.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

The investigators objective of this study is to evaluate the effectiveness of hematoma block versus intravenous regional anesthesia (Bier block) during closed reduction of distal radius fractures.

Primary Outcome

VAS pain score (0 no pain - 10 severe pain)

Conditions Studied

Interventions

  • DRUG Hematoma Local Anesthetic Block Procedure with 1% Lidocaine
  • DRUG Bier Anesthetic Block Procedure with 1% Lidocaine

Study Locations (1)

Utah

  • University of Utah Orthopaedic Center - Salt Lake City

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2021-07-15
Est. Completion 2025-07
Phase Early Phase 1
University of Utah

818 total trials

What the registry record for NCT05086224 still lists

NCT05086224 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 71-participant average among 4 other Distal Radius Fractures trials with a reported enrollment target (604% higher).

The record links to 1 condition, with Distal Radius Fractures appearing as the primary indexed condition, and to 2 interventions - of which Hematoma Local Anesthetic Block Procedure with 1% Lidocaine is the first listed.

NCT05086224 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT05086224 about?

NCT05086224 is a clinical study titled "Hematoma Block Versus Bier Block for Closed Fracture Reduction". The investigators objective of this study is to evaluate the effectiveness of hematoma block versus intravenous regional anesthesia (Bier block) during closed reduction of distal radius fractures.

What is the current status of trial NCT05086224?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 500 participants. The study started on 2021-07-15. Estimated completion is 2025-07.

What conditions does trial NCT05086224 study?

This clinical trial studies the following conditions: Distal Radius Fractures.

What interventions are being tested in trial NCT05086224?

The interventions under investigation include: Hematoma Local Anesthetic Block Procedure with 1% Lidocaine (DRUG), Bier Anesthetic Block Procedure with 1% Lidocaine (DRUG).

Who is sponsoring clinical trial NCT05086224?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05086224 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Distal Radius Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05086224, the US trial registry maintained by the National Library of Medicine. NCT05086224 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.